-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on AdaptHealth, Raises Price Target to $15

Benzinga·11/06/2025 19:55:44
Listen to the news
Canaccord Genuity analyst Richard Close maintains AdaptHealth (NASDAQ:AHCO) with a Buy and raises the price target from $14 to $15.